Breaking the pattern
How much “free” drugs cost
[PharmVestnik # 18, 02/06/2015, p. 1, cont’d pp. 4-5]
Pharmaceutical honor code
A draft document was submitted to the industry community for discussion
The pharma market players have two weeks in which to make amendments and comments to the Pharmaceutical Manufacturer Code of Conduct. The draft document was presented at the Pharmaceutical Expert Council meeting on May 25. The code that is the first chance for the market players to regulate their relationships by themselves has generated a lot of questions and made industry associations and pharma companies that have not been involved in its development so far willing to participate in its improvement.
[PharmVestnik # 18, 02/06/2015, p. 2]
A TWIGA media agency to improve healthcare image
The Ministry of Health managed to save 670 thousand RUB when it made the contract for forming a positive image of the Russian healthcare. Media First International, a TWIGA company, won the bidding. Thus, creating a positive image of the industry that has recently attracted most criticism was evaluated at 54.97 mn RUB.
[PharmVestnik # 18, 02/06/2015, p. 1, cont’d p. 3]
Block, control, and own
Rostech doesn’t mind increasing its share of Fort LLC
According to a PharmVestnik’s source, the state corporation Rostech plans to improve the asset structure of Natsimbio pharma holding company it owns. Natsimbio has already started operating Microgen as well as RT-Biotechprom. Besides, the holding company has blocking ownership of Kurgan Sintez and Fort. Now it makes sense increasing shares of these companies. Truly speaking, so far, Rostech has been getting all assets for free, that being nothing else than rotation of the government property. And now, bringing the formation of the holding company to its logical end will require ready cash.
[PharmVestnik # 18, 02/06/2015, p. 1, cont’d p. 6]
Knock-out dose
Rx drug components detected in dietary supplements
Undeclared chemical substances increasing sexual vigor that are prohibited for use in manufacturing of dietary supplements pursuant to the Russian legislation have been detected in the formulation of the most popular supplements. In some of the samples tested the daily substance dose was exceeded 9-fold.
[PharmVestnik # 18, 02/06/2015, p. 7]
Once again out loud
Manufacturers ask that medical device circulation laws be improved
The Ministry of Industry and Trade is working on a new document that will determine the criteria for attributing industrial products to local. However, the experts and developers have not agreed on the draft document’s text so far. This fact was voiced last week at the roundtable discussion of the Russian Union of Industrialists and Entrepreneurs Commission for Pharmaceutical and Medical Industry.
[PharmVestnik # 18, 02/06/2015, p. 8]
On Pharma business without any lyrics
In May, the “Editorial Fireplace” rubric invited CEO of Pfizer Russia Danil BLINOV. He told PharmVestnik Editor-in-Chief Herman Inozemtsev and correspondent Polina Zvezdina about the company’s priorities, his vision of the market situation, and strategic partnership.
[PharmVestnik # 18, 02/06/2015, p. 9]
What makes pharmacists different from lawyers?
Pharma-2020 program changed demand for training specialists at pharmaceutical universities
Pharmaceutical companies’ demand for specialists changes from year to year under the impact of many circumstances, the major of them being the import substitution policy by the state and the development of the domestic pharma industry. What skills must a Pharma university graduate have in order to build a career in drug research and development? What opportunities for developing these skills students currently have? PharmVestnik observer Anna Kurskaya discussed these issues with Igor NARKEVICH, Rector of St. Petersburg State Chemical and Pharmaceutical Academy.
[PharmVestnik # 18, 02/06/2015, p. 10]
Pharmacists to make it stage by stage
A fresh view of pharmacist training
By July 2015, the development of a primary accreditation program for graduates of the Russian pharmaceutical departments and universities is to be completed. All higher learning institutions will have to switch to the Federal State Education Standard 4 for Pharmaceutics starting from the new academic year. Such information was voiced in late May at a joint meeting of the Educational & Methodological Association and Educational & Methodological Commission of the Russian Ministry of Education and Science.
[PharmVestnik # 18, 02/06/2015, p. 12]
Billion-worth insurance
After social and economic upsets of the last year that have been further aggravated by corruption scandals, the Yaroslavl region makes efforts for finding rational solutions for a decent drug coverage of beneficiaries. Rostislav DANILENKO, Deputy Chairman for Social Policy of the Yaroslavl region, who has headed this block since the autumn of 2014, told PharmVestnik correspondent Svetlana Petrova about the work done and plans for the future.
[PharmVestnik # 18, 02/06/2015, p. 13]
Hacking hepatitis
In early April, unknown hackers attacked five Russian websites on hepatitis C. A massive DoS attack affected both large forums and social networks such as HV-info, НСV.info, promo.mirodin.com, algeron.ru as well as BIOCAD’s website. Experts believe that was an unprecedented attack on hepatitis C-related web resources in Russia.
[PharmVestnik # 18, 02/06/2015, p. 13]
Consulting, not dispensing
A heated discussion in Siberia on the right way to sell OTC drugs
Pharma industry representatives met on May 20 within the framework of the interregional conference “Current Issues of Regulating Medical Drug Circulation’ in Novosibirsk. The hottest issue was pharmaceutical consulting.
[PharmVestnik # 18, 02/06/2015, p. 14]
Research Japanese style
Innovative development leads to globalization of pharmaceutical manufacturers
New drug R&D is the costliest part of pharmaceutical companies’ activities, and each of them chooses its own strategy in this field. How is R&D investment related to building a company’s presence worldwide? What are the principles for selecting candidate molecules? These were just a few of the questions that PharmVestnik observer Anna Kurskaya addressed to Haruhiko HIRATE, Takeda Director for Corporate Communications and PR, Chairman of the International Relations Committee under Japan Pharmaceutical Manufacturers Association.
[PharmVestnik # 18, 02/06/2015, p. 15]
Dry ration
Russian Pharma profits measure up on the world scale, but no-frills
Russia is not represented in the world super-profitable pharma corporations rating. However, that does not mean that Russian companies pale into insignificance in benchmarking with others. Although there are no super-profits, the margin of profit is in some cases higher than that of the Big Pharma. There is one sticking point, however: fingers of one hand are enough to count high-profit companies in Russia.
[PharmVestnik # 18, 02/06/2015, p. 17]
Change of leader
Rating of Russian pharmacy chains as of Q115
For pharmaceutical retailers, the beginning of the year was marked not only by a persistent economic crisis, fluctuation of demand, and a number of regulatory initiatives. It was also marked by the change of the industry leader: the rating in terms of the drug market share is now led by A.v.e Group.
[PharmVestnik # 18, 02/06/2015, pp. 18-20]
Advertising boom
Experts determined Pharma industry leaders in terms of direct advertising costs
Notwithstanding the fact the direct advertising cost ratings see changes annually, there is still room for surprise.
[PharmVestnik # 18, 02/06/2015, p. 21]
Adaptive pricing tools
This is a newspaper version of the book “Practical Tools of Increasing Pharmacy Business Profitability” that is planned for publishing. It continues a series of articles dwelling on key provisions of an economic approach to pricing as well as describing typical mistakes.
[PharmVestnik # 18, 02/06/2015, pp. 22-23]
Dream came true
When appointed a manager, an employee needs methodical support for the management as well as training and coaching as companies often risk losing a good salesman/saleswoman while acquiring a bad manager. It is important to overcome the managing player syndrome in the new manager, make him/her use the right style of working with the team as well as form in him/her a sense of belonging to the company’s management.
[PharmVestnik # 18, 02/06/2015, p. 26]
Import and protect
Logistics is part and parcel of any business. It is especially important for the pharma industry, as it goes about special storage and transportation conditions. Harold VLASOV, COO of NC Pharm Logistic, told PharmVestnik about the current situation with logistics in the industry.
[PharmVestnik # 18, 02/06/2015, p. 26]
